Digenis G A, Agha B J, Tsuji K, Kato M, Shinogi M
J Med Chem. 1986 Aug;29(8):1468-76. doi: 10.1021/jm00158a025.
The design and synthesis of 13 novel peptidyl carbamates are described. When tested for inhibitory activity toward porcine pancreatic elastase, trypsin, and chymotrypsin, six compounds were found to specifically inhibit elastase without affecting the other two serine proteases. All the active inhibitors had an amino acid isostere at the P1 position. Kinetic studies indicated that the inhibition was competitive with Ki values ranging from 4.23 X 10(-5) to 2.4 X 10(-6) M. The degree of inhibition was found to be dependent on the specificity of the peptide chain for the extended subsites on the enzyme as well as on the nature of P1'. Preliminary work on one inhibitor indicates that the inhibition is reversible and proceeds via the rapid formation of a strong enzyme-inhibitor complex, followed by slow acylation of the serine residue on the active site of the enzyme. Peptidyl carbamates represent a novel class of elastase inhibitors.
本文描述了13种新型肽基氨基甲酸酯的设计与合成。在对猪胰弹性蛋白酶、胰蛋白酶和胰凝乳蛋白酶的抑制活性进行测试时,发现有6种化合物能特异性抑制弹性蛋白酶,而不影响其他两种丝氨酸蛋白酶。所有活性抑制剂在P1位都有一个氨基酸等排体。动力学研究表明,抑制作用具有竞争性,Ki值范围为4.23×10⁻⁵至2.4×10⁻⁶ M。发现抑制程度取决于肽链对酶上延伸亚位点的特异性以及P1'的性质。对一种抑制剂的初步研究表明,抑制作用是可逆的,通过快速形成强酶 - 抑制剂复合物,随后缓慢酰化酶活性位点上的丝氨酸残基来进行。肽基氨基甲酸酯代表了一类新型的弹性蛋白酶抑制剂。